celecoxib has been researched along with Obsessive-Compulsive Disorder in 4 studies
Obsessive-Compulsive Disorder: An anxiety disorder characterized by recurrent, persistent obsessions or compulsions. Obsessions are the intrusive ideas, thoughts, or images that are experienced as senseless or repugnant. Compulsions are repetitive and seemingly purposeful behavior which the individual generally recognizes as senseless and from which the individual does not derive pleasure although it may provide a release from tension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Westwell-Roper, C | 1 |
| Best, JR | 1 |
| Elbe, D | 1 |
| MacFadden, M | 1 |
| Baer, S | 1 |
| Tucker, L | 1 |
| Au, A | 1 |
| Naqqash, Z | 1 |
| Lin, B | 1 |
| Lu, C | 1 |
| Stewart, SE | 1 |
| Garabadu, D | 1 |
| Kumar, V | 1 |
| Shalbafan, M | 1 |
| Mohammadinejad, P | 1 |
| Shariat, SV | 1 |
| Alavi, K | 1 |
| Zeinoddini, A | 1 |
| Salehi, M | 1 |
| Askari, N | 1 |
| Akhondzadeh, S | 1 |
| Sayyah, M | 1 |
| Boostani, H | 1 |
| Pakseresht, S | 1 |
| Malayeri, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Celecoxib Versus Placebo as an Adjunct to Treatment-as-usual in Children and Youth With Obsessive-compulsive Disorder: A Single-site Randomized Quadruple-blind Phase II Study[NCT04673578] | Phase 2 | 80 participants (Anticipated) | Interventional | 2021-06-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for celecoxib and Obsessive-Compulsive Disorder
| Article | Year |
|---|---|
Celecoxib versus placebo as an adjunct to treatment-as-usual in children and youth with obsessive-compulsive disorder: protocol for a single-site randomised quadruple-blind phase II study.
Topics: Adolescent; Adult; Canada; Celecoxib; Child; Clinical Trials, Phase II as Topic; Cyclooxygenase 2 In | 2022 |
Celecoxib as an Adjuvant to Fluvoxamine in Moderate to Severe Obsessive-compulsive Disorder: A Double-blind, Placebo-controlled, Randomized Trial.
Topics: Adolescent; Adult; Antidepressive Agents; Celecoxib; Cyclooxygenase 2 Inhibitors; Double-Blind Metho | 2015 |
A preliminary randomized double-blind clinical trial on the efficacy of celecoxib as an adjunct in the treatment of obsessive-compulsive disorder.
Topics: Adult; Antidepressive Agents, Second-Generation; Celecoxib; Cyclooxygenase 2 Inhibitors; Double-Blin | 2011 |
1 other study available for celecoxib and Obsessive-Compulsive Disorder
| Article | Year |
|---|---|
Celecoxib potentiates the antianxiety and anticompulsive-like activity of fluoxetine against chronic unpredictable mild stress in experimental animals.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Celecoxib; Compulsive Behavior; Disease Mod | 2019 |